# CIPAMI-Study: Clopidogrel Administered Prehospital to Improve Primary PCI in Patients With Acute Myocardial Infarction

> **NCT00372216** · PHASE3 · COMPLETED · sponsor: **Stiftung Institut fuer Herzinfarktforschung** · enrollment: 337 (actual)

## Conditions studied

- Myocardial Infarction

## Interventions

- **DRUG:** Clopidogrel (Iscover/Plavix)

## Key facts

- **NCT ID:** NCT00372216
- **Lead sponsor:** Stiftung Institut fuer Herzinfarktforschung
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2009-10
- **Final completion:** 2010-01
- **Target enrollment:** 337 (ACTUAL)
- **Last updated:** 2010-11-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00372216

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00372216, "CIPAMI-Study: Clopidogrel Administered Prehospital to Improve Primary PCI in Patients With Acute Myocardial Infarction". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00372216. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*